10x Genomics, Inc. (TXG): Cost of Revenue
$198.94M
Year ended 2025-12-31
$184.88M
Trailing 12 months to 2026-06-30
+18.2%
3-year compound annual growth
+27.8%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $198.94M | +1.3% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $196.30M | -6.3% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $209.41M | +74.0% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $120.39M | +62.5% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $74.09M | +26.7% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $58.47M | -4.2% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $61.03M | +112.9% | 2022-02-18, From 2019-01-01 |
| 2018-12-31 | $28.66M | +171.4% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $10.56M | n/a | 2020-02-27, From 2017-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $198.94M | +1.3% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $97.03M | +8.6% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $114.22M | -2.1% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $1.24B | +4.7% |
| Quanterix Corp (QTRX) | 2025-12-31 | $73.94M | +36.1% |
| Waters Corp (WAT) | 2025-12-31 | $1.29B | +7.4% |
| Bruker Corp (BRKR) | 2025-12-31 | $1.86B | +8.3% |
| Illumina, Inc. (ILMN) | 2025-12-28 | $1.47B | -2.5% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $36.64M | -6.9% |
Compare TXG, CTKB, PACB, BIO side by side · Screen every company in Laboratory Analytical Instruments ↗